NCT03694587View on ClinicalTrials.gov

pK of a Novel 200 mg Ibuprofen Medicated Plaster

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 25, 2018

Primary Completion Date

October 18, 2018

Study Completion Date

October 18, 2018

Conditions
Healthy
Interventions
DRUG

Ibuprofen 200 mg TEPI Medicated Plaster

Ibuprofen 200mg TEPI medicated plaster applied to the upper back daily for 24 hours for 5 days

DRUG

Aktren® 200 mg überzogene Tabletten (Ibuprofen)

one dose of Aktren® 200 mg überzogene Tabletten (Ibuprofen tablet)

Trial Locations (1)

1504

Clinic of Clinical Pharmacology and Therapeutics University Multidisciplinary Hospital for Active Treatment 'Tsaritsa Ioanna-ISUL' EAD, Sofia

Sponsors

Lead Sponsor

Medherant Ltd
All Listed Sponsors
collaborator

Cooperative Clinical Drug Research and Development AG (CCDRD AG)

OTHER

lead

Medherant Ltd

INDUSTRY

NCT03694587 - pK of a Novel 200 mg Ibuprofen Medicated Plaster | Biotech Hunter | Biotech Hunter